BOC Sciences Blog

Small Molecule Drug Design Virtual Screening

Virtual Screening Strategies for Small Molecule Drug Design

Drug screening is the initial link and key to drug development. In the past, traditional drug screening methods such as animal models were often costly and time-consuming. With the development […]

ADCs Make Their Mark in HER-Positive Cancers

ADCs Make Their Mark in HER-Positive Cancers

Members of the human epidermal growth factor receptor (HER) family, including HER1 (EGFR), HER2, HER3, and HER4, play central roles in regulating cell proliferation, survival, differentiation, and migration. Overexpression of […]

Therapeutic Opportunities and Challenges for Lipogenesis Inhibitor Development

Therapeutic Opportunities and Challenges for Lipogenesis Inhibitor Development

Fatty acids are essential for cell survival and function as biological energy substrates, structural components, and signaling molecules. Given their critical role, cells have evolved mechanisms to produce fatty acids from […]

drug R&D

Small Molecule Targeted Cancer Immunotherapy Draws the New Roadmap for Cancer Treatment

As an alternative to surgery, radiotherapy, and chemotherapy, tumor therapy via the immune pathway has made significant advances in recent years. Among the targeted drugs of immuno-oncology (IO), Ab drugs […]

drug development

Make the Future of Integrin Targeted Cancer Therapeutics Brighter

Integrins are cell adhesion and signaling proteins that play important roles in a wide range of biological functions. Currently, integrin-targeting drugs have been extensively developed in areas including cardiovascular disease, […]

PARP1 structure and function

Beyond PARP1 Single-Target Inhibitors–Combined Therapy Reveals More Possibilities

In late 2014, the PARP inhibitor Olaparib was approved to treat ovarian cancer with BRCA mutations. Since then, research in the field of PARP has received extensive attention, especially in […]

Covalent and Non-Covalent BTK Inhibitors: Development and Applications

What Is the Potential of BTK Inhibitors?

B Cell Receptor (BCR) signaling pathway overview BCR is a transmembrane protein complex that controls B cell maturation, survival, apoptosis, and the production of plasma cell antibodies starting from the […]

Small Molecule Drugs for Cancer Immunotherapy

Progress and Promise: Small Molecule Drugs for Cancer Immunotherapy

Overview of cancer immunotherapy The most widely studied cancer immunotherapies are PD-1/PD-L1 immune checkpoint inhibitors and chimeric antigen receptor-T cell (CAR-T) therapy. With the expanded clinical applications, some defects of […]

Nucleoside Monomers

Breaking the Barrier: Chemical Modification of Nucleoside Monomers

Small nucleic acid-based drugs, namely oligonucleotide drugs, are short-chain nucleic acids consisting of dozens of nucleotides in series. At present, most oligonucleotide drugs are obtained through solid-phase chemical synthesis by […]

10 Small Molecule Drugs Approved for COVID-19

A Glance at 10 Small Molecule Drugs Approved for COVID-19

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a betacoronavirus and possesses a positive-sense single-stranded RNA genome that contains 14 open reading frames (ORFs). Two […]